Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

PHASE2CompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Contraceptives, Oral
Interventions
DRUG

YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300)

SH T 00186 D in a 24-day regimen, i.e., 24 verum tablets, 4 placebo tablets Dose: 0.02 mg EE, 3 mg DRSPMode of administration: Oral, 1 tablet dailyDuration of treatment: 3 cycles of 28 days each

DRUG

Yasminelle (SH T 00186 D)

SH T 00186 D in a 21-day regimen, i.e., 21 verum tablets, 7 placebo tablets Dose: 0.02 mg EE, 3 mg DRSPMode of administration: Oral, 1 tablet dailyDuration of treatment: 3 cycles of 28 days each

Trial Locations (1)

9713 GZ

Groningen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY